Skip to main content

2 Result(s)

within Dominik Harzheim Remove this filter

and

  1. No Access

    Article

    Safety and Long-Term Efficacy of Transition from Sildenafil to Tadalafil due to Side Effects in Patients with Pulmonary Arterial Hypertension

    Two phosphodiesterase-type 5 (PDE-5) inhibitors, sildenafil and tadalafil, are approved for treatment of pulmonary arterial hypertension (PAH). It has not yet been observed if transition from sildenafil to tad...

    Mona Lichtblau, Dominik Harzheim, Nicola Ehlken, Alberto Marra, Fabiola Pena Pinado… in Lung (2015)

  2. Article

    Open Access

    Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

    The objective of this prospective study was to assess the prevalence of anxiety and depression disorders and their association with quality of life (QoL), clinical parameters and survival in patients with pulm...

    Dominik Harzheim, Hans Klose, Fabiola Peña Pinado, Nicola Ehlken… in Respiratory Research (2013)

    Download PDF (798 KB) View Article